LORI BLAKE: Open Payments
NPI 1255397220 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $131 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Astellas Pharma US Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $35 |
| ABBVIE INC. | 1 | $25 |
| Globus Medical, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Resmed Corp | 1 | $17 |
Products named: Ozempic, Veozah, The Cologuard Plus Collection Kit, Rybelsus, VRAYLAR, Senza, Dexcom G6 Transmitter, FASENRA.
Industry payments across MD — which companies pay providers there.
